Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1466, 2004-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA addresses postmarketing drug surveillance concerns
Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. :
Access to resources
Recommend
Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
By Gex-Fabry M.
Drug Safety, Vol. 24, Iss. 13, 2001-01 ,pp. :
Update on the Office of Drug Safety at the US FDA
Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. :
US FDA reports new steps in drug safety
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :